Search Results - "Kim, Ju H."

RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance by McCaffrey, Timothy A, Toma, Ian, Yang, Zhaoquing, Katz, Richard, Reiner, Jonathan, Mazhari, Ramesh, Shah, Palak, Tackett, Michael, Jones, Dan, Jepson, Tisha, Falk, Zachary, Wargodsky, Richard, Shtakalo, Dmitry, Antonets, Denis, Ertle, Justin, Kim, Ju H, Lai, Yinglei, Arslan, Zeynep, Aledort, Emily, Alfaraidy, Maha, Laurent, 3rd, Georges St

“…Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery…”
Get full text

Continuous-Flow Left Ventricular Assist Device–Related Gastrointestinal Bleeding by Kim, Ju H., MD, Brophy, Donald F., PharmD, MSc, Shah, Keyur B., MD

“…Continuous-flow (CF) left ventricular assist devices (LVADs) are a safe and durable therapeutic option for patients with advanced heart failure as a bridge to…”
Get full text

The Evolution of Mechanical Circulatory Support by Kim, Ju H., MD, Cowger, Jennifer A., MD, MS, Shah, Palak, MD, MS

“…The field of mechanical circulatory support (MCS) has evolved from earlier-generation pulsatile-flow devices that were primarily used to support critically ill…”
Get full text

Ventricular Assist Device Therapy in Older Patients with Heart Failure: Characteristics and Outcomes by Kim, Ju H., MD, Singh, Ramesh, MD, Pagani, Francis D., MD, PhD, Desai, Shashank S., MD, Haglund, Nicholas A., MD, Dunlay, Shannon M., MD, MS, Maltais, Simon, MD, PhD, Aaronson, Keith D., MD, MS, Stulak, John M., MD, PhD, Davis, Mary E., MS, Salerno, Christopher T., MD, Cowger, Jennifer A., MD, MS, Shah, Palak, MD, MS

“…Abstract Background Limited data exist on outcomes in patients greater than 70 years of age supported with continuous flow left ventricular assist devices…”
Get full text

Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications by Kim, Ju H., Shah, Palak, Tantry, Udaya S., Gurbel, Paul A.

“…Heart failure (HF) represents a heterogeneous condition characterized by vulnerabilities in the blood, vasculature, and impaired flow dynamics that predispose…”
Get full text

Within-the-Clinic Shared Decision for an Over-the-Counter Medication by Kim, Ju H, Borden, William B

Get full text

Criteria for Defining Stages of Cardiogenic Shock Severity by Kapur, Navin K., Kanwar, Manreet, Sinha, Shashank S., Thayer, Katherine L., Garan, A. Reshad, Hernandez-Montfort, Jaime, Zhang, Yijing, Li, Borui, Baca, Paulina, Dieng, Fatou, Harwani, Neil M., Abraham, Jacob, Hickey, Gavin, Nathan, Sandeep, Wencker, Detlef, Hall, Shelley, Schwartzman, Andrew, Khalife, Wissam, Li, Song, Mahr, Claudius, Kim, Ju H., Vorovich, Esther, Whitehead, Evan H., Blumer, Vanessa, Burkhoff, Daniel

“…BACKGROUNDRisk-stratifying patients with cardiogenic shock (CS) is a major unmet need. The recently proposed Society for Cardiovascular Angiography and…”
Get full text

Use of Tissue Plasminogen Activator Alteplase for Suspected Impella Thrombosis by Succar, Luma, Donahue, Kevin R., Varnado, Sara, Kim, Ju H.

“…Background Impella devices are being increasingly used to manage cardiogenic shock. The incidence of thrombosis and hemolysis in patients on Impella support…”
Get full text

Degree of change in right ventricular adaptation measures during axillary Impella support informs risk stratification for early, severe right heart failure following durable LVAD implantation by Hsi, Brian, Joseph, Denny, Trachtenberg, Barry, Bhimaraj, Arvind, Suarez, Erik E., Xu, Jiaqiong, Guha, Ashrith, Kim, Ju H.

“…Risk assessment for early, severe right heart failure (RHF) after LVAD implantation remains imperfect. We sought to define the differences in RV adaptation and…”
Get full text

A case series analysis of bicarbonate-based purge solution administration via Impella ventricular assist device by Sigala, Mariah I, Harris, Jesse E, Morton, Celia, Donahue, Kevin R, Kim, Ju H

“…Abstract Purpose The Impella device historically required a heparin-based purge solution to reduce the risk of biomaterial deposition to maintain pump…”
Get full text

Management of Cardiogenic Shock in a Cardiac Intensive Care Unit by Kim, Ju H, Sunkara, Anusha, Varnado, Sara

“…Cardiogenic shock (CS) is a complex condition characterized by end-organ hypoperfusion and requiring pharmacologic and/or mechanical circulatory support. It is…”
Get full text

A novel approach for identifying causal models of complex diseases from family data by Park, Leeyoung, Kim, Ju H

“…Causal models including genetic factors are important for understanding the presentation mechanisms of complex diseases. Familial aggregation and segregation…”
Get full text

Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report by Ton, Van-Khue, Li, Song, John, Kevin, Li, Borui, Zweck, Elric, Kanwar, Manreet K, Sinha, Shashank S, Hernandez-Montfort, Jaime, Garan, A Reshad, Goodman, Rachel, Faugno, Anthony, Farr, Maryjane, Hall, Shelley, Kataria, Rachna, Guglin, Maya, Vorovich, Esther, Pahuja, Mohit, Vallabhajosyula, Saraschandra, Nathan, Sandeep, Abraham, Jacob, Harwani, Neil M, Hickey, Gavin W, Schwartzman, Andrew D, Khalife, Wissam, Mahr, Claudius, Kim, Ju H, Bhimaraj, Arvind, Sangal, Paavni, Kong, Qiuyue, Walec, Karol D, Zazzali, Peter, Fried, Justin, Burkhoff, Daniel, Kapur, Navin K

“…The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) staging was developed to risk stratify…”
Get full text

Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group by Kochar, Ajar, Vallabhajosyula, Saraschandra, John, Kevin, Sinha, Shashank S., Esposito, Michele, Pahuja, Mohit, Hirst, Colin, Li, Song, Kong, Qiuyue, Li, Borui, Natov, Peter, Kanwar, Manreet, Hernandez-Montfort, Jaime, Garan, A. Reshad, Walec, Karol, Zazzali, Peter, Sangal, Paavni, Ton, Van-Khue, Zweck, Elric, Kataria, Rachna, Guglin, Maya, Vorovich, Esther, Nathan, Sandeep, Abraham, Jacob, Harwani, Neil M., Fried, Justin A., Farr, Maryjane, Hall, Shelley A., Hickey, Gavin W., Wencker, Detlef, Schwartzman, Andrew D., Khalife, Wissam, Mahr, Claudius, Kim, Ju H., Bhimaraj, Arvind, Blumer, Vanessa, Faugno, Anthony, Burkhoff, Daniel, Kapur, Navin K.

“…There are limited data depicting the prevalence and ramifications of acute limb ischemia (ALI) among cardiogenic shock (CS) patients. We employed data from the…”
Get full text

Clinical Course of Patients in Cardiogenic Shock Stratified by Phenotype by Zweck, Elric, Kanwar, Manreet, Li, Song, Sinha, Shashank S., Garan, A. Reshad, Hernandez-Montfort, Jaime, Zhang, Yijing, Li, Borui, Baca, Paulina, Dieng, Fatou, Harwani, Neil M., Abraham, Jacob, Hickey, Gavin, Nathan, Sandeep, Wencker, Detlef, Hall, Shelley, Schwartzman, Andrew, Khalife, Wissam, Mahr, Claudius, Kim, Ju H., Vorovich, Esther, Whitehead, Evan H., Blumer, Vanessa, Westenfeld, Ralf, Burkhoff, Daniel, Kapur, Navin K.

“…Cardiogenic shock (CS) patients remain at 30% to 60% in-hospital mortality despite therapeutic innovations. Heterogeneity of CS has complicated clinical trial…”
Get full text

Outflow cannula alignment in continuous flow left ventricular devices is associated with stroke by Kassi, Mahwash, Agrawal, Tanushree, Xu, Jiaqiong, Marcos-Abdala, Hernan Gerardo, Araujo-Gutierrez, Raquel, Macgillivray, Thomas, Suarez, Erik E, Yousefzai, Rayan, Fida, Nadia, Kim, Ju H, Hussain, Imad, Guha, Ashrith, Trachtenberg, Barry, Bhimaraj, Arvind, Chang, Su Min, Estep, Jerry

“…We sought to evaluate whether differences in left ventricular assist device (LVAD) canula alignment are associated with stroke. There is a paucity of clinical…”
Get full text

Impact of Female Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report by Ton, Van-Khue, Kanwar, Manreet K, Li, Borui, Blumer, Vanessa, Li, Song, Zweck, Elric, Sinha, Shashank S, Farr, Maryjane, Hall, Shelley, Kataria, Rachna, Guglin, Maya, Vorovich, Esther, Hernandez-Montfort, Jaime, Garan, A Reshad, Pahuja, Mohit, Vallabhajosyula, Saraschandra, Nathan, Sandeep, Abraham, Jacob, Harwani, Neil M, Hickey, Gavin W, Wencker, Detlef, Schwartzman, Andrew D, Khalife, Wissam, Mahr, Claudius, Kim, Ju H, Bhimaraj, Arvind, Sangal, Paavni, Zhang, Yijing, Walec, Karol D, Zazzali, Peter, Burkhoff, Daniel, Kapur, Navin K

“…Studies reporting cardiogenic shock (CS) outcomes in women are scarce. The authors compared survival at discharge among women vs men with CS complicating acute…”
Get full text

Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation by Kenneth Sims, Robert, Srour, Nina, El Nihum, Lamees I, Hannawi, Bashar, Araujo-Gutierrez, Raquel, Cruz-Solbes, Ana S, Trachtenberg, Barry H, Hussain, Imad, Kim, Ju H, Kassi, Mahwash, Graviss, Edward A, Nguyen, Duc T, Estep, Jerry, Bhimaraj, Arvind, Guha, Ashrith

“…Objectives: We sought to examine the efficacy and safety of adding fibrinogen-guided low-dose multi-day Alteplase™ tissue plasminogen activator (tPA) in the…”
Get full text

Remote versus early corticosteroid wean outcomes in heart transplant recipients in the contemporary era by Salgado, Benjamin C., Fida, Nadia, Krisl, Jill, Berens, Pauline M., Graviss, Edward. A., Nguyen, Duc T., Hussain, Imad, Kim, Ju H., Suarez, Erik, Trachtenberg, Barry, Torre‐Amione, Guillermo, Bhimaraj, Arvind, Guha, Ashrith

“…Purpose The risks and benefits of remote corticosteroid weaning in heart transplant recipients more than 2 years post‐transplant are unknown. We compared…”
Get full text

Effect of chronic kidney disease on the expression of thiamin and folic acid transporters by Bukhari, Farhan J., Moradi, Hamid, Gollapudi, Pavan, Ju Kim, Hyun, Vaziri, Nosratola D., Said, Hamid M.

“…Background . Chronic kidney disease (CKD) is associated with significant cardiovascular, neurological and metabolic complications. Thiamin and folate are…”
Get full text